Mixing the right hepatitis C inhibitor cocktail
- 23 November 2010
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 17 (1) , 34-46
- https://doi.org/10.1016/j.molmed.2010.10.005
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individualsJournal of Hepatology, 2010
- Replicated Association Between an IL28B Gene Variant and a Sustained Response to Pegylated Interferon and RibavirinGastroenterology, 2010
- Multiple Effects of Silymarin on the Hepatitis C Virus LifecycleHepatology, 2010
- Viral Reorganization of the Secretory Pathway Generates Distinct Organelles for RNA ReplicationCell, 2010
- HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A–cyclophilin A interaction to cyclophilin inhibitorsJournal of Hepatology, 2010
- Hepatitis C virus evasion of adaptive immune responses: a model for viral persistenceImmunologic Research, 2010
- Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis CVaccine, 2009
- A Functional Genomic Screen Identifies Cellular Cofactors of Hepatitis C Virus ReplicationCell Host & Microbe, 2009
- A virocidal amphipathic α-helical peptide that inhibits hepatitis C virus infection in vitroProceedings of the National Academy of Sciences, 2008
- Production of infectious hepatitis C virus in tissue culture from a cloned viral genomeNature Medicine, 2005